Fine-needle aspiration cytology for the diagnosis of metastatic melanoma: Systematic review and meta-analysis

Brian J. Hall, Robert L. Schmidt, Rohit R. Sharma, Lester J. Layfield

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Objectives: To perform a thorough review and meta-analysis of studies that have shown non-image-guided fine-needle aspiration cytology (FNAC) to be highly sensitive and specific for assessing questionable metastatic melanoma to lymph nodes. Methods: MEDLINE and Scopus were searched for potentially relevant articles with a search string including the words "melanoma" and "fine needle." All relevant articles were screened by two authors (B.J.H. and R.L.S.). Full articles were screened for extractable data, and the data was pooled for analysis. Results: Of 978 unique studies found, 10 (5,518 cases) met our inclusion criteria. In a pooled analysis of palpation and ultrasound-guided fine-needle aspirations, the area under the receiver operating characteristic curve was 0.99 (95% confidence interval [CI], 0.99-1.00). The summary estimates for the sensitivity and specificity were 0.97 (95% CI, 0.95- 0.98) and 0.98 (95% CI, 0.98-1.00), respectively. Conclusions: With a sensitivity and specificity of 0.97 and 0.99, the overall diagnostic accuracy of FNAC for metastatic melanoma is quite high, and with a positive and negative likelihood ratio of 58 and 0.03, FNAC for metastatic melanoma should be the first-line option in a patient with a clinically suspected mass and a history of melanoma.

Original languageEnglish (US)
Pages (from-to)635-642
Number of pages8
JournalAmerican Journal of Clinical Pathology
Volume140
Issue number5
DOIs
StatePublished - Nov 2013

Fingerprint

Fine Needle Biopsy
Cell Biology
Meta-Analysis
Melanoma
Confidence Intervals
Sensitivity and Specificity
Palpation
MEDLINE
ROC Curve
Needles
Lymph Nodes

Keywords

  • AP cytopathology
  • Fine-needle aspiration
  • Melanoma
  • Meta-analysis
  • Metastatic melanoma
  • Surgical oncology
  • Systematic review

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Fine-needle aspiration cytology for the diagnosis of metastatic melanoma : Systematic review and meta-analysis. / Hall, Brian J.; Schmidt, Robert L.; Sharma, Rohit R.; Layfield, Lester J.

In: American Journal of Clinical Pathology, Vol. 140, No. 5, 11.2013, p. 635-642.

Research output: Contribution to journalArticle

@article{ed621529d2f441b68b3491783805638e,
title = "Fine-needle aspiration cytology for the diagnosis of metastatic melanoma: Systematic review and meta-analysis",
abstract = "Objectives: To perform a thorough review and meta-analysis of studies that have shown non-image-guided fine-needle aspiration cytology (FNAC) to be highly sensitive and specific for assessing questionable metastatic melanoma to lymph nodes. Methods: MEDLINE and Scopus were searched for potentially relevant articles with a search string including the words {"}melanoma{"} and {"}fine needle.{"} All relevant articles were screened by two authors (B.J.H. and R.L.S.). Full articles were screened for extractable data, and the data was pooled for analysis. Results: Of 978 unique studies found, 10 (5,518 cases) met our inclusion criteria. In a pooled analysis of palpation and ultrasound-guided fine-needle aspirations, the area under the receiver operating characteristic curve was 0.99 (95{\%} confidence interval [CI], 0.99-1.00). The summary estimates for the sensitivity and specificity were 0.97 (95{\%} CI, 0.95- 0.98) and 0.98 (95{\%} CI, 0.98-1.00), respectively. Conclusions: With a sensitivity and specificity of 0.97 and 0.99, the overall diagnostic accuracy of FNAC for metastatic melanoma is quite high, and with a positive and negative likelihood ratio of 58 and 0.03, FNAC for metastatic melanoma should be the first-line option in a patient with a clinically suspected mass and a history of melanoma.",
keywords = "AP cytopathology, Fine-needle aspiration, Melanoma, Meta-analysis, Metastatic melanoma, Surgical oncology, Systematic review",
author = "Hall, {Brian J.} and Schmidt, {Robert L.} and Sharma, {Rohit R.} and Layfield, {Lester J.}",
year = "2013",
month = "11",
doi = "10.1309/AJCPWSDDHLLW40WI",
language = "English (US)",
volume = "140",
pages = "635--642",
journal = "American Journal of Clinical Pathology",
issn = "0002-9173",
publisher = "American Society of Clinical Pathologists",
number = "5",

}

TY - JOUR

T1 - Fine-needle aspiration cytology for the diagnosis of metastatic melanoma

T2 - Systematic review and meta-analysis

AU - Hall, Brian J.

AU - Schmidt, Robert L.

AU - Sharma, Rohit R.

AU - Layfield, Lester J.

PY - 2013/11

Y1 - 2013/11

N2 - Objectives: To perform a thorough review and meta-analysis of studies that have shown non-image-guided fine-needle aspiration cytology (FNAC) to be highly sensitive and specific for assessing questionable metastatic melanoma to lymph nodes. Methods: MEDLINE and Scopus were searched for potentially relevant articles with a search string including the words "melanoma" and "fine needle." All relevant articles were screened by two authors (B.J.H. and R.L.S.). Full articles were screened for extractable data, and the data was pooled for analysis. Results: Of 978 unique studies found, 10 (5,518 cases) met our inclusion criteria. In a pooled analysis of palpation and ultrasound-guided fine-needle aspirations, the area under the receiver operating characteristic curve was 0.99 (95% confidence interval [CI], 0.99-1.00). The summary estimates for the sensitivity and specificity were 0.97 (95% CI, 0.95- 0.98) and 0.98 (95% CI, 0.98-1.00), respectively. Conclusions: With a sensitivity and specificity of 0.97 and 0.99, the overall diagnostic accuracy of FNAC for metastatic melanoma is quite high, and with a positive and negative likelihood ratio of 58 and 0.03, FNAC for metastatic melanoma should be the first-line option in a patient with a clinically suspected mass and a history of melanoma.

AB - Objectives: To perform a thorough review and meta-analysis of studies that have shown non-image-guided fine-needle aspiration cytology (FNAC) to be highly sensitive and specific for assessing questionable metastatic melanoma to lymph nodes. Methods: MEDLINE and Scopus were searched for potentially relevant articles with a search string including the words "melanoma" and "fine needle." All relevant articles were screened by two authors (B.J.H. and R.L.S.). Full articles were screened for extractable data, and the data was pooled for analysis. Results: Of 978 unique studies found, 10 (5,518 cases) met our inclusion criteria. In a pooled analysis of palpation and ultrasound-guided fine-needle aspirations, the area under the receiver operating characteristic curve was 0.99 (95% confidence interval [CI], 0.99-1.00). The summary estimates for the sensitivity and specificity were 0.97 (95% CI, 0.95- 0.98) and 0.98 (95% CI, 0.98-1.00), respectively. Conclusions: With a sensitivity and specificity of 0.97 and 0.99, the overall diagnostic accuracy of FNAC for metastatic melanoma is quite high, and with a positive and negative likelihood ratio of 58 and 0.03, FNAC for metastatic melanoma should be the first-line option in a patient with a clinically suspected mass and a history of melanoma.

KW - AP cytopathology

KW - Fine-needle aspiration

KW - Melanoma

KW - Meta-analysis

KW - Metastatic melanoma

KW - Surgical oncology

KW - Systematic review

UR - http://www.scopus.com/inward/record.url?scp=84886281871&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886281871&partnerID=8YFLogxK

U2 - 10.1309/AJCPWSDDHLLW40WI

DO - 10.1309/AJCPWSDDHLLW40WI

M3 - Article

C2 - 24124141

AN - SCOPUS:84886281871

VL - 140

SP - 635

EP - 642

JO - American Journal of Clinical Pathology

JF - American Journal of Clinical Pathology

SN - 0002-9173

IS - 5

ER -